Mithila Samachar

Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2030

 Breaking News
  • No posts were found

Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2030

September 04
19:30 2020
Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2030

(Albany, US) DelveInsight has launched a new report on Prader-Willi Syndrome Market

 

DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Prader-Willi Syndrome, historical and forecasted epidemiology as well as the Prader-Willi Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Prader-Willi Syndrome market report provides current treatment practices, emerging drugs, Prader-Willi Syndrome market share of the individual therapies, current and forecasted Prader-Willi Syndrome market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Prader-Willi Syndrome treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

 

According to the US National Library of Medicine, Prader-Willi syndrome is a complex genetic condition that affects many parts of the body. This condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development in infancy. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. Some people with Prader-Willi syndrome, particularly those with obesity, also develop type 2 diabetes (the most common form of diabetes). The disease occurs due to the loss of function of several genes in a particular region of chromosome number 15. Among these are genes that provide instructions for making molecules called small nucleolar RNAs (snoRNAs). According to NORD, Prader-Will syndrome (PWS) is the first syndromic form of the neurodevelopmental disorder that was confirmed to be caused due to imprinting errors leading to a multisystem genetic disorder characterized during infancy by lethargy, diminished muscle tone (hypotonia), feeding difficulties, poor weight gain and growth hormone deficiency. Although considered a “rare” disorder, PWS is one of the most common conditions seen in genetic clinics and is the most common genetic cause of obesity that has been identified to date.

 

View Free Sample Page:- https://www.delveinsight.com/sample-request/prader-willi-syndrome-market

 

Prader-Willi Syndrome Treatment

Currently, there is no cure for PWS. The lives of individuals with PWS can be improved with early diagnosis and careful management of symptoms, but more effective therapies are needed. The treatment of PWS is currently based on treating the symptoms of the disorder as they arise. Growth hormone deficiency is present in almost all children and many adults with PWS. In multiple studies, human growth hormone (HGH) has been found to be beneficial for those with Prader-Willi syndrome. In June of 2000, HGH was officially approved by the Federal Drug Administration (FDA) in the United States for use in patients with Prader-Willi syndrome. HGH is effective not only in increasing height, but also in decreasing body fat, increasing muscle mass, improving weight distribution, increasing stamina, and increasing bone mineral density. Some of the major approved GH therapies include Pfizer’s Genotropin (somatropin) along with other major brands such as Norditropin (Novo Nordisk) and a few others in the US.

 

Prader-Willi Syndrome Market

The Prader-Willi Syndrome market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Prader-Willi Syndrome market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment gives a thorough detail of Prader-Willi Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

 

Prader-Willi Syndrome Report Scope

  • The report covers the descriptive overview of Prader-Willi Syndrome, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Prader-Willi Syndrome epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Prader-Willi Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Prader-Willi Syndrome market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Prader-Willi Syndrome market

 

Download Free Sample Page:- https://www.delveinsight.com/sample-request/prader-willi-syndrome-market

 

Table of content

1. Key Insights

2. Executive Summary of Prader-Willi Syndrome

3. Competitive Intelligence Analysis for Prader-Willi Syndrome

4. Prader-Willi Syndrome: Market Overview at a Glance

5. Prader-Willi Syndrome: Disease Background and Overview

6. Patient Journey

7. Prader-Willi Syndrome Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Prader-Willi Syndrome Treatment

11. Marketed Products

12. Emerging Therapies

13. Prader-Willi Syndrome: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Prader-Willi Syndrome

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Prader-Willi Syndrome market
  • To understand the future market competition in the Prader-Willi Syndrome market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Prader-Willi Syndrome in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Prader-Willi Syndrome market
  • To understand the future market competition in the Prader-Willi Syndrome market

 

Related Reports

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/